Results 211 to 220 of about 690,479 (320)

Ubiquitination in hepatocellular carcinoma immunity. [PDF]

J Transl Med
Zhao J, Li Y, Zhu J, Li H, Jin X.
europepmc   +1 more source

RADIOFREQUENCY ABLATION OF THE PREVALENCE IN THE TREATMENT OF HEPATOCELLULAR CARCINOMA: A PERSPECTIVE OF HUMAN SCIENCES

, 1970
Mário Fabrício Fleury Rosa, Suélia de Siqueira Rodrigues   +1 more
openalex   +2 more sources

Hepatocellular carcinoma in woodchuck hepatitis virus-infected woodchucks: Presence of viral DNA in tumor tissue from chronic carriers and animals serologically recovered from acute infections [PDF]

, 1989
Brent E. Korba, Frances V. Wells, B. H. Baldwin, Paul J. Côté, Bud C. Tennant, Hans Pópper, John L. Gerin   +6 more
openalex   +1 more source

Mitochondrial Regulation of CD8⁺ T Cells: Mechanisms and Therapeutic Modulation

Advanced Science, EarlyView.
This article comprehensively explores the pivotal role of mitochondrial function in CD8⁺ T cell immunotherapy. It highlights how mitochondrial dynamics regulate T cell activation, differentiation, and persistence, and how mitochondrial dysfunction leads to immune exhaustion and impaired antitumor/antiviral responses.
Xu Chen, Pei Lin, Ye Lu, Jiarong Zheng, Yunfan Lin, Zihao Zhou, Li Cui, Xinyuan Zhao   +7 more
wiley   +1 more source

Hepatocellular carcinoma, hepatitis B and measles

, 1979
G H Rée
openalex   +1 more source

Identification and Drug Screening of Single Cells from Human Tumors on Semiconductor Chip for Cancer Precision Medicine

Advanced Science, EarlyView.
The study innovatively integrates single‐cell electric impedance identification and drug screening on a semiconductor chip, addressing tumor heterogeneity limitations. The system achieves label‐free cancer cell recognition while concurrently evaluating drug efficacy on cancer cells and toxicity on noncancerous cells.
Wenhao Hui, Ka‐Meng Lei, Yingying Liu, Xinru Huang, Yunlong Zhong, Xiaojun Chen, Mingji Wei, Jie Yan, Ren Shen, Pui‐In Mak, Rui P. Martins, Shuhong Yi, Ping Wang, Yanwei Jia   +13 more
wiley   +1 more source

Treatment Outcomes of Systemic Therapies for Infiltrative Hepatocellular Carcinoma. [PDF]

J Hepatocell Carcinoma
Chen PY, Chang CK, Chen BB, Hsu CH, Cheng AL, Shao YY.   +5 more
europepmc   +1 more source

Splenoportographic Findings of Hepatocellular Carcinoma

, 1978
Atsushi Toyonaga, T Satomi, Masatake Yasumoto, S. Kuratomi, Hisaaki KAJI, Yoshikazu Nagasaki, T. Fujimi, Ei Sasaki, Kazuo Fukuda, Kyuichi Tanikawa, Kazuyoshi Sakamoto   +10 more
openalex   +2 more sources

DDAH1 Promotes Cisplatin Chemoresistance in Patients with Locally Advanced Nasopharyngeal Carcinoma via the EGFR‐JAK2‐STAT3 Pathway

Advanced Science, EarlyView.
This study identifies a novel mechanism of nasopharyngeal carcinoma (NPC) cisplatin chemoresistance that DDAH1 expression is associated with cisplatin resistance in NPC cells primarily through the enhancement of the phosphoinositide Janus kinase 2 (JAK2)‐signal transducer and activator of transcription 3 (STAT3) pathway.
Jin‐Hao Yang, Li Yuan, Qiu‐Yan Chen, Kai‐Qi Lan, Liang‐Ji Li, Yu‐Chen Li, Xiao‐Yun Li, Xue‐Song Sun, Lin‐Quan Tang, Sai‐Lan Liu, Hai‐Qiang Mai   +10 more
wiley   +1 more source

Mechanisms of drug resistance in hepatocellular carcinoma. [PDF]

Biol Proced Online
Zou Y, Wan X, Zhou Q, Zhu G, Lin S, Tang Q, Yang X, Wang S.   +7 more
europepmc   +1 more source